Research Centre on Vascular Ageing and Stroke

R&D Centre

VASCage is a new and unique R&D Centre on Vascular Ageing and Clinical Stroke Research.

Science meets industry

We combine the international expertise of top scientists and leading research companies.

Our vision

is to extend the healthy lifespan in the ageing community by promoting vascular health.

Our strengths

  • outstanding clinical and epidemiological expertise
  • the alliance with several large hospitals
  • broad access to patients
  • an own clinical trial platform

Our shareholders

  • Medical University of Innsbruck
  • University of Innsbruck


  • ambitious prevention programs
  • improving diagnosis, therapy and rehabilitation
  • enabling better coping with the effects of stroke

News & Events

VACAge Nature Communications paper on Corona biomarkers

VASCage Proteomics and RNA biomarker research contributes with a new publication to fight the pandemic

A ‘Nature Communications‘ paper on prognostic COVID-19 biomarkers for intensive care patients has been published.
COVID-19 poses an unprecedented challenge to health care systems globally. It is increasingly apparent that conventional prognostic scores for patients admitted to intensive care units (ICUs) are unsuitable for outcome prediction. Now VASCage project leader Manuel Mayr of King’s College London, and his team were able to make important contributions to address this clinicial need.
pulse wave velocity measurement

PRESS RELEASE:  First signs of atherosclerosis in Tyrolean Youths? Largest clinical trial on vascular health in adolescents in Austria

EVA4YOU is an observational study enrolling students and apprentices aged between 14 and 19 years to determine predictors of the early steps of the formation of atherosclerosis. Examinations are conducted at schools and companies throughout Tyrol.
Link to press release (in German)
Download press picture 1 ©VASCage/M.Knoflach
Download press picture 2 ©VASCage/M.Knoflach
Link to the trial EVA4YOU